Hyaluronic acid to prevent radiation cystitis in bladder cancer
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests whether giving hyaluronic acid directly into the bladder can prevent radiation-induced bladder inflammation in people receiving chemoradiation for muscle-invasive bladder cancer. You may benefit if you are planning bladder-preserving treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have muscle-invasive bladder cancer (stage T2 to T4a) that has not spread to other organs.
- You are scheduled to receive chemoradiation instead of having your bladder removed.
- You are at least 19 years old and in fairly good health (able to care for yourself).
- You have normal bladder function and the tumor can be mostly removed with a scope procedure.
- You have no active bladder infection or had frequent infections in the past 6 months.
- You are not allergic to hyaluronic acid, and if you could become pregnant, you agree to use birth control.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a shorter, more focused radiation plan given at the same time as chemotherapy can control muscle-invasive bladder cancer while keeping the bladder. You may be offered bladder-preserving treatment if your cancer stage and health conditions fit the study rules.
This study tests a new treatment for radiation cystitis, a bladder condition caused by past pelvic radiation. It combines stem-cell derived particles with a standard bladder instillation to see if it helps improve symptoms like urgency or blood in urine.
This trial studies whether pentosan polysulfate sodium can reduce bladder bleeding (hematuria) and urinary symptoms caused by radiation cystitis after pelvic cancer radiation. It may help people who are still having these bladder problems more than 6 months after radiation.
This trial tests whether hyperbaric oxygen therapy (breathing pure oxygen in a pressurized chamber) can improve symptoms and reduce inflammation in people with bladder damage from past pelvic radiation. It compares patients with radiation cystitis to those without it.
This trial tests a new online adaptive radiotherapy technique for bladder cancer that adjusts the radiation plan daily based on changes in the bladder. It aims to improve treatment accuracy and reduce side effects.
This trial tests whether radiation therapy can help people whose bladder cancer (specifically carcinoma in situ) did not get better with BCG treatment and who are not having their bladder removed. It aims to offer a less invasive option for controlling the cancer.
Hear when a new Bladder Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.